Collaboration will leverage Alphamab’s antibody drug conjugate (“ADC”) research and discovery platform and ArriVent’s global development and commercialization expertise Upfront and milestone payments to Alphamab worth up to $615.5 million for potential ADCs SUZHOU, China and NEWTOWN SQUARE, Pa., June 05, 2024 (GLOBE NEWSWIRE) -- ArriVent BioPharma, Inc., (“ArriVent”) a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that t ...

收入和利润 - 公司第一季度总收入为245亿美元，同比下降3.1%[39] - 调整后的每股收益为2.03美元，同比下降1.0%[37] - 销售总额为241.43亿美元，同比下降3.2%[39] - 其他收入为3.88亿美元，同比增加3.9%[39] - 营业利润为12.96亿美元，同比下降2.4%[39] - 毛利率为27.7%，同比增加1.4个百分点[46] - 销售及行政管理费用率为21.1%，同比增加1.3个百分点[47] 现金流量和财务状况 - 经营活动产生的现金流量为11亿美元，同比下降15.4%[36] - 公司现金及现金等价物余额为36亿美元，其中包括短期投资27亿美元[62] - 经营活动产生的现金流量为11亿美元，较去年同期减少2亿美元[63] - 投资活动所需现金减少至7亿美元，较去年同期减少9亿美元[65] - 公司拥有10亿美元364天和30亿美元无担保循环信贷额度，分别于2024年和2028年到期[70] 投资和债务 - 税后投资回报率为15.4%，同比增加4个百分点[38] - 公司长期债务评级为A2、A、A，商业票据评级为P-1、A-1、F1[69] 库存和运营 - 店铺数量从1956家增加到1963家[48] - 库存为117亿美元，较上季度和去年同期分别减少2亿美元和9亿美元[64] 股息和股票回购 - 公司支付的股息总额为508亿美元，每股股息为110美元，较去年同期增长19%[66] - 公司未在报告期内回购任何股票[67] 其他财务信息 - 公司预计新会计准则不会对财务报表产生重大影响[73] - 公司报告未提及市场风险管理有重大变化[76]

文章核心观点 - 2023年第一季度公司业绩表现稳健,盈利能力持续改善,收入增长和利润率均超预期 [1][2] - 2024年第一季度"7大明星"公司业绩增长51.2%,但剔除这些公司后其他公司业绩反而下降1.5% [3] - 2023年全年S&P 500指数整体预计增长9.0%,但剔除科技行业后仅增长6.2% [4] 行业分析 - 零售行业方面,Target公司业绩表现不佳,而沃尔玛则凭借在高收入家庭的市场份额增长实现了业绩超预期 [5][6][7] - 科技行业业绩表现强劲,预计2023年增长16.0%,是拉动整体市场增长的主要动力 [11][12][13][14] - 能源行业对整体市场增长有一定拖累,但剔除能源和科技行业后其他行业增长12.7% [12]

ToplineWalgreens is cutting prices on more than 1,300 items as part of its “Summer of Savings,” the drug store chain announced Wednesday, joining a slew of big-box retailers slashing prices to boost sales amid persistent inflation.Walgreens is reducing prices for more than 1,300 items, it said Wednesday. Getty Images Key FactsIncluded in the price slash are name brand and store brand products, including its health and wellness, personal care and seasonal lines—such as facial cleansers, vitamins and summer e ...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- ExGen Resources Inc. (TSX.V: EXG; OTC: BXXRF) (“ExGen”, the “Company”) is pleased to provide an update in respect of Phoenix Copper Ltd.’s (“Phoenix”) exploration and development activities at the Empire Mine Project in Custer County, Idaho, USA, further to Phoenix’s news release of May 15, 2024. ExGen owns 20% and Phoenix owns 80% of Konnex Resource ...

It’s not uncommon to see blue-chip stocks trading at a valuation premium. The reasons include low-beta, dividends, share repurchase and stable cash flows. However, the markets tend to be sensitive to news or quarterly numbers. Therefore, temporary weakness in quality blue-chip stocks presents a good opportunity to buy quality names. This column focuses on blue-chip stocks to buy that trade at attractive levels after weak Q1 results.As a long-term investor, focus on the vision for growth and value creation t ...

TORONTO, May 28, 2024 (GLOBE NEWSWIRE) -- Galantas Gold Corporation (TSX-V & AIM: GAL; OTCQX: GALKF) (“Galantas” or the “Company”) is pleased to announce plans to drill test the Kearney North target at the Omagh Project in County Tyrone, Northern Ireland. Mario Stifano, CEO of Galantas, commented: “We’re keen to return to surface drilling this year to test for a northern extension of the main Kearney Vein, and to explore for further dilation zones. We previously drilled 32 grams per tonne gold over 4.4 metr ...

Target seems to be falling behind Walmart in the U.S. market.Target (TGT 0.57%) recently posted its latest earnings report. For the first quarter of fiscal 2024, which ended on May 4, the retail-giant's revenue fell 3% year over year to $24.53 billion but still roughly matched analysts' expectations. Its comparable-store sales dropped nearly 4%, which marked the fourth consecutive quarter of declining comps.On the bottom line, adjusted earnings per share (EPS) dipped 1% to $2.03 and missed the consensus for ...

Target (TGT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.Over the past month, shares of this retailer have returned -11.8%, compared to the Zacks S&P 500 composite's +4.8% change. During this period, the Zacks Retail - Discount Stores industry, which Target falls in, has gained 6.5%. The key question now is: What could be the stock's future direction?Although m ...

aroax We think Smith & Wesson (NASDAQ:SWBI) is an undervalued company that could potentially be the target of M&A activity, amid the recent interest in one of its closest competitors: Vista Outdoor. The valuation attached to the company is currently low, as suggested by both public comparables and the multiples of recent takeovers in the industry. Last but not least, the demand for guns seems strong and could sustain SWBI's growth. We initiate the name with a buy rating and a target price of $18. An int ...